AP technical glitch unintentionally breaks JAMA Avastin study embargo
The story on “Treatment-Related Mortality With Bevacizumab in Cancer Patients” showed up on the Taiwan News site sometime before 2 p.m Eastern. JAMA/Archives spokesperson Jann Ingmire tells Embargo Watch:
AP has called to confess that some faulty software caused the story to get out early. AP is contacting the websites to ask them to take the stories down. It was not an intentional break.
It’s unclear where else the story appeared before the embargo lifted, but Taiwan News did not take it down.